Background: Alveolar-capillary membrane diffusion evaluated by carbon monoxide diffusion (DLCO) plays an important role in heart failure (HF). Cardiopulmonary exercise test (CPET) is a powerful diagnostic and prognostic tool in this context. Surfactant Proteins (SPs) have also been suggested as a worthwhile marker in these patients. In HF, Levosimendan improves cardiopulmonary hemodynamics and reduces lung fluids but associated SPs and DLCO changes are unknown. Purpose: To show changes in serum SPs values and in CPET parameters after Levosimendan administration in patients with advanced HF. Methods: Sixty-five advanced HF patients (NYHA class III/IV, VO2 = 12 underwent complete spirometry, CPET and SPs determination before and after Levosimendan infusion. Results: Levosimendan caused a significant natriuretic peptide-B (BNP) reduction (from 954 to 370 ng/ml*), peakVO2 increase (from 10.1±2.4 to 11.5±2.3 mL/kg/min*) and VE/VCO2 slope reduction (from 42±10 to 36±7*) (* = p < 0.01, Tab.1). FEV1, FVC and alveolar volume increased but DLCO did not. SP-A, SP-D and immature SP-B reduced while mature SP-B increased (Fig.1). Spirometry, BNP and CPET changes suggest an hemodynamic improvement and lung fluid reduction after inotropic drug infusion. In parallel SP-A, SP-D and immature SP-B reduction indicates an alveolar-capillary membrane hemodynamic and general inflammatory stress reduction. Conversely, mature SP-B increase suggests an alveolar cell function restoration. Conclusions: Levosimendan improves VO2 peak, decreases VE/VCO2 slope and decreases plasma levels of BNP. Hemodynamic improvement and acute lung fluid reduction is associated with SPs but not DLCO changes. SPs are fast responders to alveolar-capillary membrane condition changes.

Surfactant proteins changes after acute hemodynamic improvement in patients with advanced chronic heart failure treated with Levosimendan / M. Mapelli, J. Campodonico, C. Banfi, E. Spadafora, E. Salvioni, C. Vignati, S. Sciomer, A. Del Torto, F. Nicoli, N. Corrieri, M. Contini, P. Agostoni. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1879-0844. - 20:suppl. 1(2018), pp. 1551.385-1551.385.

Surfactant proteins changes after acute hemodynamic improvement in patients with advanced chronic heart failure treated with Levosimendan

M. Mapelli
;
C. Banfi;E. Spadafora;E. Salvioni;C. Vignati;A. Del Torto;F. Nicoli;N. Corrieri;P. Agostoni
2018

Abstract

Background: Alveolar-capillary membrane diffusion evaluated by carbon monoxide diffusion (DLCO) plays an important role in heart failure (HF). Cardiopulmonary exercise test (CPET) is a powerful diagnostic and prognostic tool in this context. Surfactant Proteins (SPs) have also been suggested as a worthwhile marker in these patients. In HF, Levosimendan improves cardiopulmonary hemodynamics and reduces lung fluids but associated SPs and DLCO changes are unknown. Purpose: To show changes in serum SPs values and in CPET parameters after Levosimendan administration in patients with advanced HF. Methods: Sixty-five advanced HF patients (NYHA class III/IV, VO2 = 12 underwent complete spirometry, CPET and SPs determination before and after Levosimendan infusion. Results: Levosimendan caused a significant natriuretic peptide-B (BNP) reduction (from 954 to 370 ng/ml*), peakVO2 increase (from 10.1±2.4 to 11.5±2.3 mL/kg/min*) and VE/VCO2 slope reduction (from 42±10 to 36±7*) (* = p < 0.01, Tab.1). FEV1, FVC and alveolar volume increased but DLCO did not. SP-A, SP-D and immature SP-B reduced while mature SP-B increased (Fig.1). Spirometry, BNP and CPET changes suggest an hemodynamic improvement and lung fluid reduction after inotropic drug infusion. In parallel SP-A, SP-D and immature SP-B reduction indicates an alveolar-capillary membrane hemodynamic and general inflammatory stress reduction. Conversely, mature SP-B increase suggests an alveolar cell function restoration. Conclusions: Levosimendan improves VO2 peak, decreases VE/VCO2 slope and decreases plasma levels of BNP. Hemodynamic improvement and acute lung fluid reduction is associated with SPs but not DLCO changes. SPs are fast responders to alveolar-capillary membrane condition changes.
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Article (author)
File in questo prodotto:
File Dimensione Formato  
An unusual case of aborted sudden cardiac death in a young woman - which is the culprit.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 102.16 MB
Formato Adobe PDF
102.16 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/736989
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact